Kala Pharmaceuticals
KALA
$6.75
Share price
-2.81%
Change (1 day)
-55.53%
Change (1 year)
Categories
EPS for Kala Pharmaceuticals (KALA)
EPS in 2023 (TTM): $0.07000
According to Kala Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $0.07000. In 2022 the company made an earnings per share (EPS) of -$29.68 an increase over its 2021 EPS that were of -$108.93.
EPS history for Kala Pharmaceuticals from 2016 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.07000 | -100.24% |
| 2022 | -$29.68 | -72.75% |
| 2021 | -$108.93 | 8.39% |
| 2020 | -$100.50 | -27.17% |
| 2019 | -$138.00 | 12.65% |
| 2018 | -$122.50 | 19.14% |
| 2017 | -$102.82 | 7.16% |
| 2016 | -$95.95 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.27 | -485.71% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$1.00 | -1,528.57% | 🇺🇸 USA |